The clinical effectiveness of denosumab (Prolia) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis

Nicolopoulos K, Moshi MR, Stringer D, Ma N, Jenal M, Vreugdenburg T
Record ID 32018004626
Project Status: Completed
Year Published: 2023
URL for published report:
Requestor: Arch Osteoporos, 18(1), 18.
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
Pubmed ID: 36624318
MeSH Terms
  • Bone Density
  • Bone Density Conservation Agents
  • Osteoporosis
  • Denosumab
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Neoplasms
  • Ibandronic Acid
  • Hormones
  • Risedronic Acid
  • Zoledronic Acid
Organisation Name: Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address: ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name:
Contact Email:
Copyright: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.